pyrroles has been researched along with Hypertension, Pulmonary in 115 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (2.61) | 18.7374 |
1990's | 1 (0.87) | 18.2507 |
2000's | 16 (13.91) | 29.6817 |
2010's | 80 (69.57) | 24.3611 |
2020's | 15 (13.04) | 2.80 |
Authors | Studies |
---|---|
Bigby, TD; Breen, EC; Cannon, DT; Gilmore, NK; Gutierrez-Gonzalez, AK; Nogueira, L | 1 |
Akar, FG; Akar, JG; Bisserier, M; Cacheux, M; Fargnoli, A; Hadri, L; Hummel, JP; Katz, MG; Obus, E; Sassi, Y; Strauss, B | 1 |
Chen, J; Dai, Y; Nie, X; Shen, C; Sun, H; Tan, J; Wang, W; Wu, Z; Yang, X | 1 |
Anderson, SA; Chen, LY; Danner, RL; Dougherty, EJ; Elinoff, JM; Gairhe, S; Johnston, KA; Lu, M; Mazer, AJ; Nelson, JNH; Noguchi, A; Siddique, MAH; Solomon, MA; Solomon, SB; Sun, J; Vanderpool, RR; Wang, H; Wang, S; Yu, ZX; Zou, Y | 1 |
Ghofrani, HA; Grimminger, F; Hadzic, S; Kojonazarov, B; Schermuly, RT; Seeger, W; Weissmann, N | 2 |
Bogaard, HJ; Chaudhary, KR; Hansmann, G; Legchenko, E; Stewart, DJ; Sun, XQ | 1 |
Aliotta, JM; Borgovan, T; Brodsky, AS; Del Tatto, M; Dooner, MS; Goldberg, LR; Klinger, JR; Liang, OD; Pereira, M; Quesenberry, PJ; Ventetuolo, CE; Wen, S; Wu, KQ | 1 |
Ackermann, M; Bogaard, HJ; Chaudhary, KR; Hansmann, G; Jonigk, DD; Kühnel, MP; Legchenko, E; Stewart, DJ; Sun, X | 1 |
Abman, SH; Le Cras, TD | 1 |
Jin, R; Jin, Z; Paudel, O; Sham, JSK; Xia, L; Xia, Y | 1 |
Chen, H; Chen, J; Chen, Y; Duan, X; He, W; Hou, C; Jiang, Q; Kuang, M; Li, Y; Liao, J; Liu, S; Lu, W; Luo, X; Tang, H; Wang, J; Yan, H; Yang, K; Zheng, Q; Zhou, Y; Zou, G | 1 |
Bikou, O; Hadri, L; Hajjar, RJ; Sassi, Y | 1 |
Bian, JS; Chen, J; Chen, Y; Dai, Y; Nie, X; Shen, C; Tan, J; Wang, W; Wu, Z; Yang, X; Ye, S | 1 |
Bogaard, HJ; de Raaf, MA; Schalij, I | 1 |
Blankenberg, FG; Deuse, T; Fadel, E; Guihaire, J; Reichenspurner, H; Schrepfer, S; Spin, JM; Wang, D | 1 |
Gupte, SA; Jacob, C; Jordan, A; Kitagawa, A; McMurtry, IF; Waddell, I | 1 |
Awada, C; Bonnet, S; Boucherat, O; Bourgeois, A; Breuils-Bonnet, S; Grobs, Y; Lemay, SE; Nadeau, V; Orcholski, M; Paulin, R; Provencher, S; Romanet, C; Shimauchi, K; Toro, V; Tremblay, E | 1 |
Chen, G; He, Y; Jia, D; Liu, H; Lu, A; Yu, Y; Zhu, Q; Zuo, C | 1 |
Fujiwara, Y; Hayashi, T; Ijiri, Y; Imano, H; Izumi, Y; Kato, R; Katsumata, T; Okada, Y; Woo, E; Yamaguchi, T; Yoshiyama, M | 1 |
Bernhard, JC; Daste, A; François, L; Gross-Goupil, M; Laine, M; Ravaud, A | 1 |
Baust, J; Chang, B; Goda, A; Goncharov, D; Goncharova, EA; Gorcsan, J; Kobir, A; Kudryashova, TV; Mora, AL; Pena, A; Ray, A; Vanderpool, R | 1 |
Chen, J; Chen, Y; Geng, H; Guo, X; Huang, Y; Lai, Z; Luo, HB; Wu, D; Wu, Y; Yu, Y; Zhang, C; Zhang, T | 1 |
Kato, F; Nishimura, R; Sakao, S; Suzuki, T; Takeuchi, T; Tanabe, N; Tatsumi, K; Yasuda, T | 1 |
Melnyk, O; Shults, NV; Suzuki, YJ; Zungu-Edmondson, M | 1 |
Dean, A; Docherty, CK; Gregorc, T; Harvey, KY; MacLean, MR; Morrell, NW; Nilsen, M | 1 |
Higuchi, M; Hikasa, Y; Leong, ZP; Okida, A; Yamano, Y | 1 |
Abe, K; Hoka, S; Ishikawa, T; McMurtry, IF; Oka, M; Saku, K; Sunagawa, K; Tanaka, M; Tsutsui, H; Yoshida, K | 1 |
Bigham, Z; Damarla, M; Huetsch, J; Jiang, H; Kliment, C; Servinsky, L; Shimoda, LA; Suresh, K; Yun, X | 1 |
Strielkov, I; Weissmann, N | 1 |
Barreira, B; Callejo, M; Cogolludo, A; Esquivel-Ruiz, S; Mondejar-Parreño, G; Morales-Cano, D; Moreno, L; Perez-Vizcaino, F | 1 |
D'Alessandro, A; Dixon, K; Graham, BB; Harral, J; Hernandez-Saavedra, D; Irwin, D; Kassa, B; Koyanagi, D; Kumar, R; Loomis, Z; Mickael, C; Nemkov, T; Perez, M; Sanders, L; Stenmark, KR; Tuder, RM; Valencia, C; Zhang, L | 1 |
Chen, D; Chen, G; Gao, P; Jia, D; Jing, ZC; Liu, G; Liu, J; Liu, Q; Lu, A; Qin, Z; Ruan, C; Shen, Y; Tang, J; Wang, XJ; Wang, Y; Ye, J; Yu, Y; Yuan, P; Zhang, J; Zhang, P; Zhou, Y; Zhu, Q; Zuo, C; Zuo, S | 1 |
Bueno-Beti, C; Hadri, L; Hajjar, RJ; Sassi, Y | 1 |
Hikasa, Y; Leong, ZP | 1 |
Chaudhary, KR; Deng, Y; Mei, SHJ; Petersen, TH; Stewart, DJ; Suen, CM; Taha, M | 1 |
Vitali, SH | 1 |
Fanburg, BL; Hill, NS; Penumatsa, KC; Warburton, RR | 1 |
Bastarache, J; Blackwell, TS; Bloodworth, NC; Brittain, EL; Clark, CR; D'Amico, R; Gaskill, C; Gladson, S; Majka, SM; Merryman, WD; Moore, C; Scott, C; Shay, S; Snider, JC; Tanjore, H; West, JD | 1 |
Bai, P; Fu, J; He, Y; Jia, D; Lyu, A; Lyu, L; Wan, N; Wan, Q; Yu, T; Zuo, C | 1 |
Bisserier, M; Bridges, CR; Fargnoli, AS; Gubara, SM; Hadri, L; Hajjar, RJ; Katz, MG; Sassi, Y | 1 |
Bai, P; Chen, Y; Fu, J; Li, F; Yu, T | 1 |
Damarla, M; Damico, RL; Hassoun, PM; Johnston, L; Kolb, TM; Peloquin, GL | 1 |
Abid, S; Adnot, S; Amsellem, V; Boczkowski, J; Boyer, L; Derumeaux, G; Dubois-Rande, JL; Gary-Bobo, G; Houssaini, A; Marcos, E; Mouraret, N; Saker, M | 1 |
Barrier, M; Biardel, S; Bisserier, M; Bonnet, P; Bonnet, S; Breuils-Bonnet, S; Carter, S; Courchesne, A; Courture, C; Deshaies, Y; Lauzon-Joset, JF; Majka, SM; Meloche, J; Paulin, R; Picard, F; Provencher, S; Racine, C; Tremblay, É | 1 |
Abe, K; Alzoubi, A; Fagan, KA; McMurtry, IF; O'Neill, KD; Oka, M; Rocic, P; Toba, M | 1 |
Cai, S; Fu, Z; Hu, J; Huang, C; Liedtke, W; Paudel, O; Sham, JS; Xia, Y | 1 |
Abraham, D; Baliga, R; Denton, CP; Derrett-Smith, EC; Dooley, A; Gilbane, AJ; Hobbs, AJ; Holmes, AM; Khan, K; Trinder, SL | 1 |
Aboagye, EO; Ashek, A; Barnes, G; Cotroneo, E; Cupitt, J; Dabral, S; Dubois, O; El-Bahrawy, MA; Fang, W; Gibbs, JS; Gsell, W; He, JG; Howard, LS; Jones, H; Nguyen, QD; Pullamsetti, SS; Tomasi, G; Wang, L; Wilkins, MR; Zhao, L | 1 |
Alexeyev, M; Almalouf, P; Alzoubi, A; Francis, M; McMurtry, IF; O'Neill, K; Oka, M; Qian, X; Stevens, T; Taylor, MS; Toba, M | 1 |
Ciuclan, L; Dong, L; Dubois, G; Duggan, N; Edwards, M; England, K; Hussey, M; Jarai, G; Morrell, NW; Sheppard, K; Simmons, J; Sutton, D; Thomas, M; Van Heeke, G | 1 |
Chesler, NC; Eickhoff, JC; Golob, M; Lakes, RS; Wang, Z | 1 |
Abe, K; Alzoubi, A; Gairhe, S; Matsumoto, Y; McMurtry, IF; O'Neill, KD; Oka, M; Oshima, K; Toba, M | 1 |
Emoto, N; Hirata, K; Nakayama, K; Suzuki, Y; Van Hung, T; Vignon-Zellweger, N; Yagi, K | 1 |
Chen, P; Dai, L; Wu, S; Zhang, Y; Zhao, S | 1 |
Alhussaini, AA; Bogaard, HJ; Cool, CD; Drake, JI; Farkas, D; Farkas, L; Kraskauskas, D; Kraskauskiene, V; Voelkel, NF | 1 |
Alhussaini, AA; Cool, CD; Farkas, D; Farkas, L; Kraskauskas, D; Kraskauskiene, V; Natarajan, R; Nicolls, MR | 1 |
Bálint, Z; Crnkovic, S; Egemnazarov, B; Gattinger, N; Ghanim, B; Jain, P; Klepetko, W; Kovacs, G; Kwapiszewska, G; Marsh, LM; Olschewski, A; Schermuly, RT; Seay, U; Weissmann, N | 1 |
Bogaard, HJ; de Man, FS; de Raaf, MA; Gomez-Arroyo, J; Happé, C; Rol, N; Schalij, I; Voelkel, NF; Vonk-Noordegraaf, A; Westerhof, N | 1 |
Chesler, NC; Eickhoff, JC; Hacker, TA; Liu, A; Schreier, D; Tian, L; Wang, Z | 1 |
Asmis, R; Barabutis, N; Barman, SA; Black, SM; Catravas, JD; Chen, F; Dimitropoulou, C; Fulton, DJ; Giannis, A; Han, W; Jonigk, D; Keri, G; Orfi, L; Rafikov, R; Rafikova, O; Ramesh, G; Stepp, DW; Su, Y; Szabadkai, I; Szantai-Kis, C; Wang, Y | 1 |
Abe, K; Hirano, K; Hirooka, Y; Kunita-Takanezawa, M; Kuwabara, Y; Oka, M; Sunagawa, K | 1 |
Abbate, A; Bogaard, HJ; Byron, PR; Farkas, L; Gomez-Arroyo, J; Kraskauskas, D; Mizuno, S; Sakagami, M; Syed, AA; Van Tassell, B; Voelkel, NF | 1 |
Chun, HJ; Comhair, SA; Erzurum, SC; Hu, X; Hwangbo, C; Ju, H; Kang, Y; Kim, J; McLean, DL; Mehrotra, D; Papangeli, I; Park, H | 1 |
Abe, K; Fewell, JG; Gerthoffer, WT; Joshi, SR; Matar, M; McLendon, JM; McMurtry, IF; Oka, M; Sparks, J | 1 |
Bijli, KM; Carthan, KA; Green, DE; Hart, CM; Kang, BY; Kleinhenz, JM; Murphy, TC; Park, KK; Searles, CD; Sutliff, RL; Yeligar, SM | 1 |
Gebreab, L; Graham, BB; Huber, KM; Kumar, R; Mickael, C; Perez, M; Sanders, L; Serkova, NJ; Smith-Jones, P; Tuder, RM | 1 |
Chaudhary, KR; Courtman, DW; Deng, Y; Jiang, B; Stewart, DJ; Suen, C; Taha, M | 1 |
Dohi, K; Goto, I; Ito, M; Mitani, Y; Ogihara, Y; Okamoto, R; Yamada, N | 1 |
Huetsch, JC; Jiang, H; Larrain, C; Shimoda, LA | 1 |
Bogaard, HJ; de Man, FS; de Raaf, MA; Happé, CM; Rol, N; Schalij, I; Voelkel, NF; Vonk-Noordegraaf, A; Westerhof, N | 1 |
Alexeyev, M; Stevens, T; Townsley, MI; Voelkel, NF; Zhou, C | 1 |
Chesler, NC; Eickhoff, JC; Hacker, T; Liu, A | 1 |
Chen, G; He, Y; Jia, D; Liu, H; Lu, A; Zhu, Q; Zuo, C | 1 |
Brown, MB; Goodwill, AG; Kline, JA; McCarthy, BP; Neto-Neves, EM; Persohn, SA; Rezania, S; Territo, PR; Zaretskaia, MV | 1 |
Bardou, M; Dumas, M; Goirand, F; Guerard, P; Lirussi, F; Rakotoniaina, Z; Rochette, L | 2 |
Satoh, A; Satoh, M | 1 |
Maciocia, PM | 1 |
Abbate, A; Bogaard, HJ; Chang, PJ; Chau, VQ; Hoke, NN; Kasper, M; Kraskauskas, D; Mizuno, S; Natarajan, R; Salloum, FN; Voelkel, NF | 1 |
Ozturk, EI; Uma, S | 1 |
Fan, ZX; Gao, YF; Jing, ZC; Li, J; Li, L; Ma, D; Shi, DM; Wang, YW; Wu, BX; Zhu, XD | 1 |
Lin, P; Xie, H; Xie, L; Xu, C | 1 |
Sakao, S; Tatsumi, K | 1 |
Dai, L; Wu, S | 1 |
DeFilippis, A; Eberlein, M; Girgis, RE; Iacono, A; Jones, S; Lechtzin, N; Reed, RM | 1 |
Ambalavanan, N; Järvinen, TA; Komatsu, M; Mann, D; McMurtry, I; Oka, M; Ruoslahti, E; Sawada, J; Toba, M; Urakami, T | 1 |
Casserly, B; Choudhary, G; Harrington, EO; Klinger, JR; Mazer, JM; Rounds, S; Vang, A | 1 |
Bonneau, O; Ciuclan, L; Duggan, N; Good, R; Holmes, AM; Hussey, M; Jarai, G; Jones, P; Morrell, NW; Stringer, R; Thomas, M; Walker, C; Westwick, J | 1 |
Al Hussaini, AA; Allegood, JC; Bogaard, HJ; Fadel, E; Farkas, D; Farkas, L; Guignabert, C; Humbert, M; Kraskauskas, D; Mizuno, S; Ruiter, G; Spiegel, S; Voelkel, NF; Vonk Noordegraaf, A | 1 |
Cheng, XS; Gu, Q; He, JG; Liu, ZH; Ni, XH; Shan, GL; Wilkins, MR; Xiong, CM; Xue, F; Zeng, WJ; Zhao, L; Zhao, ZH | 1 |
Al Husseini, A; Bogaard, HJ; Cool, CD; Farkas, D; Farkas, L; Gomez-Arroyo, J; Kraskauskas, D; Mizuno, S; Nicolls, MR; Voelkel, NF | 1 |
Baumann, C; Dahal, BK; Davie, N; Evans, S; Fairman, D; Ghofrani, HA; Grimminger, F; Kilty, I; Kojonazarov, B; Kosanovic, D; Luitel, H; Majewski, M; Phillips, P; Pullamsetti, SS; Schermuly, RT; Seeger, W; Sydykov, A; Tian, X; Wayman, C; Weissmann, N | 1 |
Chen, D; Chen, F; Dong, L; Ge, J; Guan, L; Qian, J; Zhou, D | 1 |
Ghofrani, HA; Grimminger, F; Kalymbetov, A; Kojonazarov, B; Kretschmer, A; Lang, M; Schermuly, RT; Seeger, W; Stasch, JP; Tian, X; Weissmann, N | 1 |
Dahan, D; Ducret, T; Estève, E; Marthan, R; Quignard, JF; Savineau, JP | 1 |
Best, J; Chwalek, K; Egemnazarov, B; Eickelberg, O; Fink, L; Kwapiszewska, G; Marsh, LM; Olschewski, A; Osswald, SL; Schermuly, RT; Seeger, W; Weisel, FC; Weissmann, N; Wilhelm, J; Wygrecka, M | 1 |
Beach, S; Bonneau, O; Burton, V; Ciuclan, L; Clay, I; Duggan, N; Fox, R; Good, R; Hussey, MJ; Jarai, G; Jones, P; Konstantinova, I; MacLean, MR; Pearce, A; Rowlands, DJ; Thomas, M; Westwick, J | 1 |
Abman, SH; Le Cras, TD; Markham, NE; Tuder, RM; Voelkel, NF | 1 |
Churg, A; Farmer, SG; Wright, JL | 1 |
Abman, SH; Kinsella, JP; Lin, YJ; Markham, NE; Maxey, A; McMurtry, IF; Tang, JR | 1 |
Fu, LJ; Li, F; Shen, J; Zhao, W; Zhou, AQ | 1 |
Cool, CD; Lee, JD; Sakao, S; Taraseviciene-Stewart, L; Voelkel, NF; Wood, K | 1 |
Alves-Filho, JC; Cunha, FQ; Figueiredo-Lopes, L; Gerlach, RF; Semprini, MC; Souza-Costa, DC; Tanus-Santos, JE | 1 |
Almog, Y; Avnon, LS | 1 |
Burns, N; Homma, N; Kraskauskas, D; McMurtry, IF; Morris, KG; Oka, M; Taraseviciene-Stewart, L; Voelkel, NF | 1 |
Boackle, SA; Burns, N; Cool, C; Kraskauskas, D; Nicolls, MR; Parr, JE; Scerbavicius, R; Taraseviciene-Stewart, L; Voelkel, NF; Wood, K | 1 |
Christians, U; Kaisers, U; Laudi, S; McMurtry, IF; Mutlak, H; Schmitz, V; Steudel, W; Trump, S; Weimann, J; West, J | 1 |
Archer, SL; Bonnet, S; Haromy, A; McMurtry, MS; Michelakis, ED | 1 |
Gamble, W; Meyrick, B; Reid, L | 1 |
Horwitz, LD; Kuriyama, T; Latham, LP; Sawada, A; Sugita, T; Wagner, WW; Watanabe, S | 1 |
Cowan, KN; Heilbut, A; Humpl, T; Ito, S; Lam, C; Rabinovitch, M | 1 |
Alger, L; Hirth, P; Kasahara, Y; Mc Mahon , G; Taraseviciene-Stewart, L; Tuder, RM; Voelkel, NF; Waltenberger, J | 1 |
Johnson, WD; Lalich, JL; Raczniak, TJ; Shumaker, RC | 1 |
Malik, AB; Pinheiro, JM | 1 |
2 review(s) available for pyrroles and Hypertension, Pulmonary
Article | Year |
---|---|
The effects of antiangiogenic compound SU5416 in a rat model of pulmonary arterial hypertension.
Topics: Angiogenesis Inhibitors; Animals; Cell Proliferation; Disease Models, Animal; Endothelial Cells; Hypertension, Pulmonary; Indoles; Pyrroles; Rats; Receptors, Vascular Endothelial Growth Factor | 2011 |
The pressure is rising.
Topics: Animals; Atorvastatin; Critical Care; Disease Models, Animal; Drug Evaluation, Preclinical; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Pulmonary; Pulmonary Embolism; Pyrroles; Rats | 2007 |
2 trial(s) available for pyrroles and Hypertension, Pulmonary
Article | Year |
---|---|
Heterogeneity in lung (18)FDG uptake in pulmonary arterial hypertension: potential of dynamic (18)FDG positron emission tomography with kinetic analysis as a bridging biomarker for pulmonary vascular remodeling targeted treatments.
Topics: Adult; Aged; Animals; Benzamides; Cell Division; Dichloroacetic Acid; Disease Models, Animal; Drug Monitoring; Familial Primary Pulmonary Hypertension; Female; Fibroblasts; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gene Expression Profiling; Glycolysis; Humans; Hypertension, Pulmonary; Imatinib Mesylate; Indoles; Lung; Male; Middle Aged; Monocrotaline; Piperazines; Positron-Emission Tomography; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Sunitinib; Young Adult | 2013 |
Atorvastatin in pulmonary arterial hypertension (APATH) study.
Topics: Adolescent; Adult; Aged; Anticholesteremic Agents; Atorvastatin; Cholesterol, LDL; Double-Blind Method; Exercise Tolerance; Familial Primary Pulmonary Hypertension; Female; Hemodynamics; Heptanoic Acids; Humans; Hypertension, Pulmonary; Lung; Male; Middle Aged; Pyrroles; Treatment Outcome; Walking; Young Adult | 2012 |
111 other study(ies) available for pyrroles and Hypertension, Pulmonary
Article | Year |
---|---|
Role of IL-33 receptor (ST2) deletion in diaphragm contractile and mitochondrial function in the Sugen5416/hypoxia model of pulmonary hypertension.
Topics: Animals; Diaphragm; Disease Models, Animal; Hypertension, Pulmonary; Hypoxia; Indoles; Interleukin-1 Receptor-Like 1 Protein; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mitochondria; Mitochondrial Diseases; Muscle Contraction; Protein Kinase Inhibitors; Pulmonary Arterial Hypertension; Pyrroles | 2022 |
Right predominant electrical remodeling in a pure model of pulmonary hypertension promotes reentrant arrhythmias.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Disease Models, Animal; Hypertension, Pulmonary; Indoles; Magnetic Resonance Imaging; Male; Pneumonectomy; Pyrroles; Rats; Rats, Sprague-Dawley; Thoracotomy; Ventricular Remodeling | 2022 |
Andrographolide Attenuates Established Pulmonary Hypertension via Rescue of Vascular Remodeling.
Topics: Animals; Anti-Inflammatory Agents; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Disease Models, Animal; Diterpenes; Female; Gene Expression Regulation; Humans; Hypertension, Pulmonary; Indoles; Male; Mice; Primary Cell Culture; Pyrroles; Signal Transduction; Vascular Remodeling | 2021 |
Mineralocorticoid receptor antagonist treatment of established pulmonary arterial hypertension improves interventricular dependence in the SU5416-hypoxia rat model.
Topics: Animals; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Humans; Hypertension, Pulmonary; Hypoxia; Indoles; Mineralocorticoid Receptor Antagonists; Pulmonary Arterial Hypertension; Pyrroles; Rats; Ventricular Dysfunction, Right | 2022 |
Reply to Bogaard
Topics: Animals; Emphysema; Hypertension, Pulmonary; Hypoxia; Indoles; Phenotype; Pulmonary Arterial Hypertension; Pyrroles; Rats | 2019 |
Emphysema Is-at the Most-Only a Mild Phenotype in the Sugen/Hypoxia Rat Model of Pulmonary Arterial Hypertension.
Topics: Animals; Emphysema; Hypertension, Pulmonary; Hypoxia; Indoles; Phenotype; Pulmonary Arterial Hypertension; Pyrroles; Rats | 2019 |
Mesenchymal Stem Cell Extracellular Vesicles Reverse Sugen/Hypoxia Pulmonary Hypertension in Rats.
Topics: Animals; Extracellular Vesicles; Fibroblasts; Humans; Hypertension, Pulmonary; Hypoxia; Indoles; Macrophage Activation; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; MicroRNAs; Muscle, Smooth; Neovascularization, Physiologic; Pyrroles; Rats, Sprague-Dawley; Vascular Remodeling; von Willebrand Factor | 2020 |
The Adult Sprague-Dawley Sugen-Hypoxia Rat Is Still "the One:" A Model of Group 1 Pulmonary Hypertension: Reply to Le Cras and Abman.
Topics: Animals; Emphysema; Hypertension, Pulmonary; Hypoxia; Indoles; Pyrroles; Rats; Rats, Sprague-Dawley | 2020 |
Early Disruption of VEGF Receptor Signaling and the Risk for Adult Emphysema.
Topics: Adult; Animals; Emphysema; Hypertension, Pulmonary; Hypoxia; Indoles; Pulmonary Emphysema; Pyrroles; Rats; Receptors, Vascular Endothelial Growth Factor | 2020 |
Cytochrome P450 Epoxygenase-Dependent Activation of TRPV4 Channel Participates in Enhanced Serotonin-Induced Pulmonary Vasoconstriction in Chronic Hypoxic Pulmonary Hypertension.
Topics: Amides; Animals; Chronic Disease; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme System; Eicosanoids; Hypertension, Pulmonary; Hypoxia; Ion Channel Gating; Male; Mice, Inbred C57BL; Morpholines; Pulmonary Artery; Pyrroles; Serotonin; TRPV Cation Channels; Vasoconstriction | 2020 |
A novel rat model of pulmonary hypertension induced by mono treatment with SU5416.
Topics: Animals; Blood Pressure; Cardiac Output; Disease Models, Animal; Heart; Hypertension, Pulmonary; Indoles; Lung; Male; Pyrroles; Rats; Rats, Sprague-Dawley; Vascular Resistance | 2020 |
Induction and Characterization of Pulmonary Hypertension in Mice using the Hypoxia/SU5416 Model.
Topics: Animals; Cell Hypoxia; Disease Models, Animal; Fibrosis; Heart Ventricles; Humans; Hydrogen-Ion Concentration; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Indoles; Male; Mice; Pulmonary Artery; Pulmonary Circulation; Pyrroles; Vascular Endothelial Growth Factor A; Vascular Remodeling; Ventricular Remodeling | 2020 |
Periostin: A Potential Therapeutic Target For Pulmonary Hypertension?
Topics: Animals; Biomarkers; Bone Morphogenetic Protein Receptors, Type II; Cell Adhesion Molecules; Cell Hypoxia; Cell Movement; Cell Proliferation; Disease Models, Animal; Endothelial Cells; Endothelin-1; Humans; Hypertension, Pulmonary; Hypoxia-Inducible Factor 1, alpha Subunit; Indoles; Membrane Glycoproteins; Mice; Myocytes, Smooth Muscle; Protein-Tyrosine Kinases; Pulmonary Artery; Pyrroles; Receptor, trkB; Vascular Endothelial Growth Factor A | 2020 |
The need for hypoxic exposure in experimental PAH - Comment on Chen et al.: a novel rat model of pulmonary hypertension induced by mono treatment with SU5416.
Topics: Animals; Hypertension, Pulmonary; Hypoxia; Indoles; Pyrroles; Rats | 2020 |
Immunomodulation Therapy Using Tolerogenic Macrophages in a Rodent Model of Pulmonary Hypertension.
Topics: Animals; Disease Models, Animal; Gene Expression Profiling; Humans; Hypertension, Pulmonary; Immune Tolerance; Immunomodulation; Immunotherapy; Indoles; Lung; Macrophages; Male; Nerve Tissue Proteins; Potassium Channels, Tandem Pore Domain; Protein Kinase Inhibitors; Pyrroles; Rats, Nude; Rodentia; Stroke Volume; Tomography, Emission-Computed, Single-Photon | 2021 |
Inhibition of Glucose-6-Phosphate Dehydrogenase Activity Attenuates Right Ventricle Pressure and Hypertrophy Elicited by VEGFR Inhibitor + Hypoxia.
Topics: Animals; Blood Pressure; Cardiomegaly; Cell Hypoxia; Cells, Cultured; DNA Methylation; Enzyme Inhibitors; Female; Glucosephosphate Dehydrogenase; Humans; Hypertension, Pulmonary; Indoles; Male; Mice; Mice, Inbred C57BL; Myocardium; Myocytes, Smooth Muscle; Pyrroles; Ventricular Function, Right | 2021 |
Preclinical Investigation of Trifluoperazine as a Novel Therapeutic Agent for the Treatment of Pulmonary Arterial Hypertension.
Topics: Animals; Antipsychotic Agents; Cardiovascular Agents; Cell Proliferation; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Repositioning; Female; Forkhead Box Protein O3; Gene Expression Regulation; Hemodynamics; Humans; Hypertension, Pulmonary; Hypoxia; Indoles; Monocrotaline; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Primary Cell Culture; Proto-Oncogene Proteins c-akt; Pulmonary Artery; Pyrroles; Rats; Rats, Sprague-Dawley; Survivin; Trifluoperazine | 2021 |
RAGE-mediated extracellular matrix proteins accumulation exacerbates HySu-induced pulmonary hypertension.
Topics: Animals; Case-Control Studies; Cell Hypoxia; Cells, Cultured; Cytoskeletal Proteins; Disease Models, Animal; DNA-Binding Proteins; Extracellular Matrix Proteins; Extracellular Signal-Regulated MAP Kinases; Female; HMGB1 Protein; Humans; Hypertension, Pulmonary; Indoles; Intracellular Signaling Peptides and Proteins; Ligands; LIM Domain Proteins; Male; Middle Aged; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pulmonary Artery; Pyrroles; Receptor for Advanced Glycation End Products; RNA Interference; S100 Calcium Binding Protein beta Subunit; Transfection; Vascular Remodeling | 2017 |
Capillary Degeneration and Right Ventricular Remodeling Due to Hypoxic Stress with Sugen5416.
Topics: Animals; Blood Pressure; Capillaries; Disease Models, Animal; Endothelial Cells; Heart Ventricles; Hypertension, Pulmonary; Hypoxia; In Situ Nick-End Labeling; Indoles; Male; MAP Kinase Signaling System; Myocardium; Myocytes, Cardiac; Oxidative Stress; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, Vascular Endothelial Growth Factor; RNA, Messenger; Ventricular Remodeling | 2017 |
Pulmonary arterial hypertension due to an intratumoral shunt: an unexpected side effect of sunitinib.
Topics: Aged; Carcinoma, Renal Cell; Heart Failure; Humans; Hypertension, Pulmonary; Indoles; Liver Neoplasms; Male; Pyrroles; Sunitinib | 2017 |
Pharmacological Inhibition of mTOR Kinase Reverses Right Ventricle Remodeling and Improves Right Ventricle Structure and Function in Rats.
Topics: Animals; Cell Proliferation; Cell Survival; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Indoles; Male; Myocytes, Cardiac; Protein Kinase Inhibitors; Pulmonary Artery; Pyrroles; Rats, Sprague-Dawley; TOR Serine-Threonine Kinases; Ventricular Remodeling | 2017 |
Discovery and Optimization of Chromeno[2,3-c]pyrrol-9(2H)-ones as Novel Selective and Orally Bioavailable Phosphodiesterase 5 Inhibitors for the Treatment of Pulmonary Arterial Hypertension.
Topics: Animals; Catalytic Domain; CHO Cells; Chromones; Cricetulus; Cytochrome P-450 CYP1A2 Inhibitors; Drug Stability; ERG1 Potassium Channel; Female; Humans; Hypertension, Pulmonary; Male; Mice; Microsomes, Liver; Molecular Docking Simulation; Molecular Dynamics Simulation; Phosphodiesterase 5 Inhibitors; Pyrroles; Rats, Sprague-Dawley; Rats, Wistar; Sildenafil Citrate; Structure-Activity Relationship | 2017 |
Endothelial cell-related autophagic pathways in Sugen/hypoxia-exposed pulmonary arterial hypertensive rats.
Topics: Animals; Autophagy; Cell Proliferation; Endothelial Cells; Hemodynamics; Hypertension, Pulmonary; Hypoxia; Indoles; Lung; Male; Pulmonary Artery; Pyrroles; Rats, Sprague-Dawley; Receptors, Vascular Endothelial Growth Factor | 2017 |
Natural reversal of pulmonary vascular remodeling and right ventricular remodeling in SU5416/hypoxia-treated Sprague-Dawley rats.
Topics: Animals; Blotting, Western; Fibrosis; Heart Ventricles; Hemodynamics; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Indoles; Lung; Male; Metabolomics; Pulmonary Artery; Pyrroles; Rats; Rats, Sprague-Dawley; Ventricular Remodeling | 2017 |
Role of the Aryl Hydrocarbon Receptor in Sugen 5416-induced Experimental Pulmonary Hypertension.
Topics: Active Transport, Cell Nucleus; Animals; Apoptosis; Aromatase; Aryl Hydrocarbon Receptor Nuclear Translocator; Azo Compounds; Cell Hypoxia; Cell Proliferation; Cytochrome P-450 CYP1A1; Endothelial Cells; Estrogens; Female; Humans; Hypertension, Pulmonary; Hypoxia-Inducible Factor 1, alpha Subunit; Indoles; Lung; Muscle, Smooth, Vascular; Pyrazoles; Pyrroles; Rats; Rats, Wistar; Receptors, Aryl Hydrocarbon; RNA, Messenger; Vascular Endothelial Growth Factor A | 2018 |
Reversal effects of low-dose imatinib compared with sunitinib on monocrotaline-induced pulmonary and right ventricular remodeling in rats.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation; Heart Ventricles; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Imatinib Mesylate; Indoles; Male; Monocrotaline; Nestin; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-raf; Pulmonary Artery; Pyrroles; Rats, Wistar; Receptor, Fibroblast Growth Factor, Type 1; Receptor, Platelet-Derived Growth Factor beta; Signal Transduction; Sunitinib; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Vascular Remodeling; Ventricular Function, Right; Ventricular Remodeling | 2018 |
Inhibition of nitric oxide synthase unmasks vigorous vasoconstriction in established pulmonary arterial hypertension.
Topics: Acetylcholine; Animals; Blood Pressure; Cyclic GMP; Hypertension, Pulmonary; Indoles; Lung; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Protein Kinase Inhibitors; Pulmonary Artery; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, Vascular Endothelial Growth Factor; Vasoconstriction | 2017 |
Reactive oxygen species induced Ca
Topics: Angiogenesis Inhibitors; Animals; Calcium; Cells, Cultured; Endothelium, Vascular; Hypertension, Pulmonary; Hypoxia; Indoles; Male; Microvessels; Pulmonary Artery; Pyrroles; Rats; Rats, Wistar; TRPV Cation Channels; Vascular Diseases | 2018 |
Role of the Aryl Hydrocarbon Receptor in Su5416/Hypoxia-induced Pulmonary Hypertension: A New Mechanism for an "Old" Model.
Topics: Animals; Apoptosis; Azo Compounds; Cell Hypoxia; Disease Models, Animal; Emphysema; Endothelial Cells; Humans; Hypertension, Pulmonary; Indoles; Mice; Protein Kinase Inhibitors; Pyrazoles; Pyrroles; Rats; Receptors, Aryl Hydrocarbon; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2 | 2018 |
miR-1 is increased in pulmonary hypertension and downregulates Kv1.5 channels in rat pulmonary arteries.
Topics: Action Potentials; Animals; Cell Hypoxia; Chlorocebus aethiops; COS Cells; Down-Regulation; Hypertension, Pulmonary; Indoles; Kv1.5 Potassium Channel; Male; MicroRNAs; Myocytes, Smooth Muscle; Potassium Channel Blockers; Pulmonary Artery; Pyrroles; Rats; Rats, Wistar | 2019 |
Vascular Adaptation of the Right Ventricle in Experimental Pulmonary Hypertension.
Topics: Adaptation, Physiological; Animals; Apoptosis; Cell Proliferation; Endothelial Cells; Female; Heart Ventricles; Hypertension, Pulmonary; Hypoxia; Indoles; Mice, Inbred C57BL; Pyrroles; Rats, Sprague-Dawley | 2018 |
Inhibition of CRTH2-mediated Th2 activation attenuates pulmonary hypertension in mice.
Topics: Adoptive Transfer; Adult; Animals; Antibodies; Blood Pressure; Bone Marrow; Cell Proliferation; Chimera; Chronic Disease; Disease Models, Animal; Female; Gene Deletion; Humans; Hypertension, Pulmonary; Hypoxia; Immunity; Indoles; Lung; Lymphocyte Activation; Male; Mice; Ovalbumin; Pulmonary Artery; Pyrroles; Receptors, Immunologic; Receptors, Prostaglandin; STAT6 Transcription Factor; Th2 Cells; Up-Regulation | 2018 |
The Sugen 5416/Hypoxia Mouse Model of Pulmonary Arterial Hypertension.
Topics: Animals; Disease Models, Animal; Humans; Hypertension, Pulmonary; Hypoxia; Indoles; Male; Mice; Mice, Inbred C57BL; Pulmonary Artery; Pyrroles; Vascular Remodeling | 2018 |
Effects of toceranib compared with sorafenib on monocrotaline-induced pulmonary arterial hypertension and cardiopulmonary remodeling in rats.
Topics: Animals; Antihypertensive Agents; Arterial Pressure; Autophagy; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Indoles; Male; Monocrotaline; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pulmonary Artery; Pyrroles; Rats, Wistar; Signal Transduction; Sorafenib; Vascular Remodeling; Ventricular Function, Right; Ventricular Remodeling | 2018 |
Efficacy of treprostinil in the SU5416-hypoxia model of severe pulmonary arterial hypertension: haemodynamic benefits are not associated with improvements in arterial remodelling.
Topics: Angiogenesis Inhibitors; Animals; Antihypertensive Agents; Epoprostenol; Hemodynamics; Hypertension, Pulmonary; Hypoxia; Indoles; Male; Protein Kinase Inhibitors; Pyrroles; Rats, Sprague-Dawley; Vascular Remodeling; Vasodilator Agents; Ventricular Function, Right | 2018 |
CrossTalk opposing view: The mouse SuHx model is not a good model of pulmonary arterial hypertension.
Topics: Angiogenesis Inhibitors; Animals; Disease Models, Animal; Hypertension, Pulmonary; Hypoxia; Indoles; Mice; Pyrroles; Receptors, Vascular Endothelial Growth Factor | 2019 |
CrossTalk proposal: The mouse SuHx model is a good model of pulmonary arterial hypertension.
Topics: Angiogenesis Inhibitors; Animals; Disease Models, Animal; Hypertension, Pulmonary; Hypoxia; Indoles; Mice; Pyrroles; Receptors, Vascular Endothelial Growth Factor | 2019 |
Bone Marrow-Derived Proangiogenic Cells Mediate Pulmonary Arteriole Stiffening via Serotonin 2B Receptor Dependent Mechanism.
Topics: Angiogenesis Inhibitors; Animals; Arterioles; Cell Lineage; Cells, Cultured; Hypertension, Pulmonary; Indoles; Lung; Mice; Mice, Inbred C57BL; Myeloid Progenitor Cells; Pyrroles; Receptor, Serotonin, 5-HT2B; Vascular Stiffness | 2018 |
Macrophage-Derived Legumain Promotes Pulmonary Hypertension by Activating the MMP (Matrix Metalloproteinase)-2/TGF (Transforming Growth Factor)-β1 Signaling.
Topics: Animals; Caspase Inhibitors; Cysteine Endopeptidases; Extracellular Matrix Proteins; Female; Follow-Up Studies; Humans; Hypertension, Pulmonary; Hypoxia; Indoles; Inflammation; Lung; Macrophages; Male; Matrix Metalloproteinase 2; Mice; Middle Aged; Monocrotaline; Pyrroles; Rats; Severity of Illness Index; Signal Transduction; Transforming Growth Factor beta1; Vascular Remodeling | 2019 |
The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats.
Topics: Animals; Disease Models, Animal; Hypertension, Pulmonary; Indoles; Lung; Male; Monocrotaline; Pneumonectomy; Pulmonary Artery; Pyrroles; Rats, Sprague-Dawley | 2019 |
Inhibition of miR-495 Improves Both Vascular Remodeling and Angiogenesis in Pulmonary Hypertension.
Topics: Angiogenic Proteins; Animals; Cell Cycle Checkpoints; Cell Movement; Cell Proliferation; Cells, Cultured; Dependovirus; Disease Models, Animal; Genetic Therapy; Genetic Vectors; Hypertension, Pulmonary; Hypoxia; Indoles; Lung; Male; Mice, Inbred C57BL; MicroRNAs; Microvessels; Neovascularization, Physiologic; Pyrroles; Recovery of Function; Signal Transduction; Vascular Remodeling | 2019 |
Severe Emphysema in the SU5416/Hypoxia Rat Model of Pulmonary Hypertension.
Topics: Animals; Disease Models, Animal; Hypertension, Pulmonary; Hypoxia; Indoles; Protein Kinase Inhibitors; Pulmonary Emphysema; Pyrroles; Rats; X-Ray Microtomography | 2019 |
SU5416 does not attenuate early RV angiogenesis in the murine chronic hypoxia PH model.
Topics: Angiogenesis Inhibitors; Animals; Chronic Disease; Heart Ventricles; Hypertension, Pulmonary; Hypoxia; Indoles; Male; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Pyrroles | 2019 |
Activation of lung p53 by Nutlin-3a prevents and reverses experimental pulmonary hypertension.
Topics: Animals; Apoptosis; Cells, Cultured; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p21; Drug Evaluation, Preclinical; Endothelial Cells; Gene Expression Regulation; Genes, p53; Humans; Hypertension, Pulmonary; Hypoxia; Imidazoles; Indoles; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Phosphorylation; Piperazines; Protein Processing, Post-Translational; Protein Stability; Pulmonary Artery; Pyrroles; Serotonin Plasma Membrane Transport Proteins; Single-Blind Method; Tumor Suppressor Protein p53; Ultrasonography | 2013 |
Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology.
Topics: Adult; Aged; Animals; Apoptosis; Arterial Pressure; Bone Morphogenetic Protein Receptors, Type II; Case-Control Studies; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Female; Glycation End Products, Advanced; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Indoles; Male; Middle Aged; Monocrotaline; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; PPAR gamma; Pulmonary Artery; Pyrroles; Rats; Rats, Sprague-Dawley; Receptor for Advanced Glycation End Products; Receptors, Immunologic; RNA Interference; S100 Proteins; Signal Transduction; STAT3 Transcription Factor; Transfection; Up-Regulation | 2013 |
Dehydroepiandrosterone restores right ventricular structure and function in rats with severe pulmonary arterial hypertension.
Topics: Animals; Apoptosis; Blood Pressure; Dehydroepiandrosterone; Fibrosis; Gene Expression; Heart Ventricles; Hypertension, Pulmonary; Hypoxia; Indoles; Male; NADP; NFATC Transcription Factors; Oxidative Stress; Pulmonary Artery; Pyrroles; Rats; Rats, Sprague-Dawley; rho-Associated Kinases; STAT3 Transcription Factor; Ventricular Dysfunction | 2013 |
TRPV4 channel contributes to serotonin-induced pulmonary vasoconstriction and the enhanced vascular reactivity in chronic hypoxic pulmonary hypertension.
Topics: Animals; Calcium Signaling; Chronic Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Familial Primary Pulmonary Hypertension; Hypertension, Pulmonary; Hypoxia; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Morpholines; Pulmonary Artery; Pyrroles; Serotonin; Sulfonamides; Time Factors; TRPV Cation Channels; Vasoconstriction; Vasoconstrictor Agents | 2013 |
Endothelial injury in a transforming growth factor β-dependent mouse model of scleroderma induces pulmonary arterial hypertension.
Topics: Angiogenesis Inhibitors; Animals; Disease Models, Animal; Endothelium, Vascular; Familial Primary Pulmonary Hypertension; Female; Hypertension, Pulmonary; Hypoxia; Indoles; Lac Operon; Male; Mice; Mice, Transgenic; Phenotype; Protein Serine-Threonine Kinases; Pulmonary Circulation; Pyrroles; Receptor, Transforming Growth Factor-beta Type II; Receptors, Transforming Growth Factor beta; Receptors, Vascular Endothelial Growth Factor; Scleroderma, Systemic; Signal Transduction; Transforming Growth Factor beta | 2013 |
TRPC4 inactivation confers a survival benefit in severe pulmonary arterial hypertension.
Topics: Angiogenesis Inhibitors; Animals; Animals, Genetically Modified; Cardiac Output; Disease Models, Animal; Hypertension, Pulmonary; Indoles; Male; Pulmonary Artery; Pyrroles; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Time Factors; TRPC Cation Channels | 2013 |
Treatment with anti-gremlin 1 antibody ameliorates chronic hypoxia/SU5416-induced pulmonary arterial hypertension in mice.
Topics: Animals; Antibodies, Monoclonal; Bone Morphogenetic Proteins; Chronic Disease; Familial Primary Pulmonary Hypertension; Heart Ventricles; HEK293 Cells; Hemodynamics; Humans; Hypertension, Pulmonary; Hypoxia; Indoles; Intercellular Signaling Peptides and Proteins; Lung; Mice; Pyrroles; Signal Transduction | 2013 |
Changes in large pulmonary arterial viscoelasticity in chronic pulmonary hypertension.
Topics: Angiogenesis Inhibitors; Animals; Blood Pressure; Chronic Disease; Collagen; Elastic Modulus; Familial Primary Pulmonary Hypertension; Hypertension, Pulmonary; Hypoxia; Indoles; Male; Mice; Mice, Inbred C57BL; Myocytes, Smooth Muscle; Proteoglycans; Pyrroles; Stress, Mechanical; Vascular Stiffness; Ventricular Dysfunction, Right; Viscosity | 2013 |
Temporal hemodynamic and histological progression in Sugen5416/hypoxia/normoxia-exposed pulmonary arterial hypertensive rats.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Angiogenesis Inhibitors; Animals; Familial Primary Pulmonary Hypertension; Hemodynamics; Hypertension, Pulmonary; Hypoxia; Indoles; Male; Pulmonary Artery; Pyrroles; Rats; Rats, Sprague-Dawley; Vasodilator Agents | 2014 |
Inhibition of vascular endothelial growth factor receptor under hypoxia causes severe, human-like pulmonary arterial hypertension in mice: potential roles of interleukin-6 and endothelin.
Topics: Animals; Biomarkers; Body Weight; Cell Hypoxia; Cell Line; Disease Models, Animal; Endothelial Cells; Endothelin-1; Heart Rate; Humans; Hypertension, Pulmonary; Indoles; Inflammation; Interleukin-6; Lung; Male; Mice; Pulmonary Artery; Pyrroles; Receptors, Vascular Endothelial Growth Factor; Signal Transduction; Up-Regulation | 2014 |
Atorvastatin attenuates involvement of RhoA/Rho-kinase pathway and NF-κB activation in hypoxic pulmonary hypertensive rats.
Topics: Animals; Atorvastatin; Blotting, Western; Heptanoic Acids; Hypertension, Pulmonary; Hypoxia; Male; NF-kappa B; Pyrroles; Random Allocation; Rats; Rats, Wistar; rho-Associated Kinases; rhoA GTP-Binding Protein; Signal Transduction | 2014 |
CXCR4 inhibition ameliorates severe obliterative pulmonary hypertension and accumulation of C-kit⁺ cells in rats.
Topics: Actins; Analysis of Variance; Animals; Arterial Occlusive Diseases; Benzylamines; Cyclams; Fluorescent Antibody Technique; Heterocyclic Compounds; Hypertension, Pulmonary; Immunohistochemistry; In Situ Hybridization; Indoles; Microscopy, Confocal; Proto-Oncogene Proteins c-kit; Pyrroles; Rats; Receptors, CXCR4; von Willebrand Factor | 2014 |
Nuclear factor κB inhibition reduces lung vascular lumen obliteration in severe pulmonary hypertension in rats.
Topics: Animals; Apoptosis; CD4-Positive T-Lymphocytes; Familial Primary Pulmonary Hypertension; Humans; Hypertension, Pulmonary; Hypoxia; Indoles; Inflammation; Interleukin-6; Leukocyte Common Antigens; Lung; NF-kappa B; Pulmonary Artery; Pyrroles; Pyrrolidines; Rats; Signal Transduction; Thiocarbamates; Time Factors | 2014 |
NPY/Y₁ receptor-mediated vasoconstrictory and proliferative effects in pulmonary hypertension.
Topics: Adult; Animals; Arginine; Cell Proliferation; Epinephrine; Female; Humans; Hypertension, Pulmonary; Hypoxia; In Vitro Techniques; Indoles; Lung; Male; Mice, Inbred C57BL; Monocrotaline; Myocytes, Smooth Muscle; Neuropeptide Y; Pulmonary Artery; Pyrroles; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Vasoconstriction; Vasoconstrictor Agents; Young Adult | 2014 |
SuHx rat model: partly reversible pulmonary hypertension and progressive intima obstruction.
Topics: Angiogenesis Inhibitors; Animals; Circadian Rhythm; Disease Models, Animal; Disease Progression; Echocardiography; Heart Ventricles; Hemodynamics; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Indoles; Lung; Male; Pulmonary Artery; Pyrroles; Rats; Rats, Sprague-Dawley; Systole; Telemetry; Tunica Intima; Vascular Remodeling | 2014 |
Direct and indirect protection of right ventricular function by estrogen in an experimental model of pulmonary arterial hypertension.
Topics: Animals; Arterial Pressure; Cardiotonic Agents; Compliance; Disease Models, Animal; Drug Implants; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Heart Ventricles; Hypertension, Pulmonary; Hypoxia; Indoles; Mice, Inbred C57BL; Myocardial Contraction; Ovariectomy; Pulmonary Artery; Pyrroles; Stroke Volume; Time Factors; Vascular Remodeling; Ventricular Dysfunction, Right; Ventricular Function, Right | 2014 |
NADPH oxidase 4 is expressed in pulmonary artery adventitia and contributes to hypertensive vascular remodeling.
Topics: Adventitia; Animals; Antihypertensive Agents; Cell Movement; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Extracellular Matrix; Familial Primary Pulmonary Hypertension; Fibroblasts; HEK293 Cells; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Indoles; Male; Mice; Mice, Inbred C57BL; Monocrotaline; NADPH Oxidase 4; NADPH Oxidases; Pulmonary Artery; Pyrroles; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Time Factors; Transfection; Up-Regulation | 2014 |
Novel dual endothelin receptor antagonist macitentan reverses severe pulmonary arterial hypertension in rats.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Indoles; Male; Pyrimidines; Pyrroles; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Sulfonamides; Time Factors; Vascular Endothelial Growth Factor A | 2014 |
Iloprost reverses established fibrosis in experimental right ventricular failure.
Topics: Animals; Collagen; Cyclic AMP-Dependent Protein Kinases; Echocardiography; Fibroblasts; Fibrosis; Heart Ventricles; Hemodynamics; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Iloprost; Indoles; Male; Matrix Metalloproteinase 9; Microscopy, Phase-Contrast; Physical Conditioning, Animal; Procollagen; Pyrroles; Random Allocation; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transforming Growth Factor beta1; Vasodilator Agents; Ventricular Function, Right | 2015 |
Restoration of impaired endothelial myocyte enhancer factor 2 function rescues pulmonary arterial hypertension.
Topics: Animals; Apelin; Arterioles; Cells, Cultured; Disease Models, Animal; Drug Evaluation, Preclinical; Endothelial Cells; Fibroblast Growth Factor 2; Hemodynamics; Histone Deacetylase Inhibitors; Hydroxamic Acids; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Intercellular Signaling Peptides and Proteins; Male; MEF2 Transcription Factors; MicroRNAs; Monocrotaline; Pulmonary Artery; Pyrroles; Rats; Rats, Sprague-Dawley; RNA Interference; RNA, Small Interfering; Transcription, Genetic | 2015 |
Lipid nanoparticle delivery of a microRNA-145 inhibitor improves experimental pulmonary hypertension.
Topics: Animals; Hypertension, Pulmonary; Hypoxia; Indoles; Lipids; Liposomes; Lung; Male; MicroRNAs; Nanoparticles; Oligonucleotides; Pyrroles; Rats, Sprague-Dawley | 2015 |
Peroxisome Proliferator-Activated Receptor γ and microRNA 98 in Hypoxia-Induced Endothelin-1 Signaling.
Topics: 3' Untranslated Regions; Animals; Binding Sites; Cell Proliferation; Cells, Cultured; Endothelial Cells; Endothelin-1; Gene Expression Regulation; Humans; Hypertension, Pulmonary; Hypoxia; Indoles; Male; Mice, Inbred C57BL; Mice, Knockout; MicroRNAs; PPAR gamma; Pulmonary Artery; Pyrroles; RNA Interference; Rosiglitazone; Signal Transduction; Thiazolidinediones; Transfection; Vascular Remodeling | 2016 |
Severe pulmonary hypertension is associated with altered right ventricle metabolic substrate uptake.
Topics: Animals; Biological Transport; Fatty Acid Transport Proteins; Fatty Acids; Female; Glucose; Heart Ventricles; Hypertension, Pulmonary; Hypoxia; Indoles; Lipoprotein Lipase; Oxidation-Reduction; Positron-Emission Tomography; Protein Kinase Inhibitors; Pyrroles; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Receptors, Vascular Endothelial Growth Factor | 2015 |
Marked Strain-Specific Differences in the SU5416 Rat Model of Severe Pulmonary Arterial Hypertension.
Topics: Animals; Disease Models, Animal; Hypertension, Pulmonary; Hypoxia; Indoles; Pyrroles; Rats; Rats, Inbred F344; Rats, Inbred Lew; Rats, Sprague-Dawley; Species Specificity | 2016 |
Detrimental Impact of Vasopressin V2 Receptor Antagonism in a SU5416/Hypoxia/Normoxia-Exposed Rat Model of Pulmonary Arterial Hypertension.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Disease Models, Animal; Hypertension, Pulmonary; Hypoxia; Indoles; Male; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin; Up-Regulation; Ventricular Remodeling | 2016 |
The Na+/H+ exchanger contributes to increased smooth muscle proliferation and migration in a rat model of pulmonary arterial hypertension.
Topics: Animals; Cell Movement; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Hypertension, Pulmonary; Indoles; Male; Myocytes, Smooth Muscle; Pyrroles; Rats; Rats, Wistar; Sodium-Hydrogen Exchangers | 2016 |
Pneumonectomy combined with SU5416 induces severe pulmonary hypertension in rats.
Topics: Animals; Blood Pressure; Disease Models, Animal; Hypertension, Pulmonary; Indoles; Male; Pneumonectomy; Pyrroles; Rats, Sprague-Dawley | 2016 |
Endothelial hyperpermeability in severe pulmonary arterial hypertension: role of store-operated calcium entry.
Topics: Animals; Arterial Pressure; Calcium Signaling; Cell Hypoxia; Endothelium, Vascular; Hypertension, Pulmonary; Indoles; Male; Permeability; Pyrroles; Rats, Inbred F344; Thapsigargin; TRPC Cation Channels | 2016 |
Estrogen Preserves Pulsatile Pulmonary Arterial Hemodynamics in Pulmonary Arterial Hypertension.
Topics: Animals; Estrogens; Female; Hypertension, Pulmonary; Indoles; Mice; Ovariectomy; Pulmonary Artery; Pulsatile Flow; Pyrroles; Vascular Resistance | 2017 |
Osteoprotegerin Disruption Attenuates HySu-Induced Pulmonary Hypertension Through Integrin αvβ3/FAK/AKT Pathway Suppression.
Topics: Animals; Arterial Pressure; Case-Control Studies; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Female; Focal Adhesion Kinase 1; Humans; Hypertension, Pulmonary; Hypoxia; Indoles; Integrin alphaVbeta3; Male; Mice, Knockout; Middle Aged; Monocrotaline; Muscle, Smooth, Vascular; Osteoprotegerin; Proto-Oncogene Proteins c-akt; Pulmonary Artery; Pyrroles; Rats, Sprague-Dawley; RNA Interference; Severity of Illness Index; Signal Transduction; Transfection; Vascular Remodeling; Walk Test | 2017 |
Chronic Embolic Pulmonary Hypertension Caused by Pulmonary Embolism and Vascular Endothelial Growth Factor Inhibition.
Topics: Animals; Cardiomegaly; Cell Proliferation; Chronic Disease; Heart Function Tests; Hemodynamics; Hyperplasia; Hypertension, Pulmonary; Hypoxia; Indoles; Ki-67 Antigen; Lung; Male; Microspheres; Oxygen Consumption; P-Selectin; Partial Pressure; Physical Conditioning, Animal; Plasminogen Activator Inhibitor 1; Polystyrenes; Pulmonary Embolism; Pyrroles; Rats, Sprague-Dawley; Tissue Inhibitor of Metalloproteinase-1; Vascular Endothelial Growth Factor A; Ventricular Dysfunction | 2017 |
Celecoxib but not the combination of celecoxib+atorvastatin prevents the development of monocrotaline-induced pulmonary hypertension in the rat.
Topics: Acetylcholine; Animals; Atorvastatin; Blotting, Western; Body Weight; Caspase 3; Celecoxib; Cyclooxygenase Inhibitors; Disease Progression; Drug Combinations; Hemodynamics; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Monocrotaline; Myocardium; Nitric Oxide Synthase Type III; Pulmonary Artery; Pyrazoles; Pyrroles; Rats; Rats, Wistar; Sulfonamides; Survival Analysis; Vasodilator Agents | 2008 |
3-Hydroxy-3-methylglutaryl (HMG)-COA reductase inhibitors and phosphodiesterase type V inhibitors attenuate right ventricular pressure and remodeling in a rat model of pulmonary hypertension.
Topics: Animals; Atorvastatin; Disease Models, Animal; Hemodynamics; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Pulmonary; Male; Monocrotaline; Phosphodiesterase Inhibitors; Pravastatin; Pulmonary Artery; Pyrroles; Rats; Rats, Wistar; Simvastatin | 2009 |
Inflammatory signaling in pulmonary arterial hypertension: the controversial role of CRP, and the search for new therapies.
Topics: Anti-Inflammatory Agents; Antihypertensive Agents; Atorvastatin; C-Reactive Protein; Chemokine CCL2; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Pulmonary; Inflammation Mediators; Interleukin-6; Muscle, Smooth, Vascular; NF-kappa B; Pulmonary Artery; Pyrroles | 2010 |
Adrenergic receptor blockade reverses right heart remodeling and dysfunction in pulmonary hypertensive rats.
Topics: Adrenergic Antagonists; Animals; Carbazoles; Carvedilol; Disease Models, Animal; Hypertension, Pulmonary; Indoles; Male; Propanolamines; Pulmonary Circulation; Pyrroles; Rats; Rats, Sprague-Dawley; Vascular Endothelial Growth Factor A; Ventricular Dysfunction, Right; Ventricular Remodeling | 2010 |
Effects of atorvastatin and L-arginine treatments on electrical field stimulation-mediated relaxations in pulmonary arterial rings of monocrotaline-induced pulmonary hypertensive rats.
Topics: Animals; Arginine; Atorvastatin; Electric Stimulation; Endothelium, Vascular; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Pulmonary; In Vitro Techniques; Male; Monocrotaline; Nitric Oxide; Nitric Oxide Synthase Type III; Pulmonary Artery; Pyrroles; Rats; Rats, Sprague-Dawley; Vasodilation | 2010 |
The effects of atorvastatin on pulmonary arterial hypertension and expression of p38, p27, and Jab1 in rats.
Topics: Animals; Atorvastatin; COP9 Signalosome Complex; Gene Expression Regulation; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Pulmonary; Intracellular Signaling Peptides and Proteins; Male; Monocrotaline; p38 Mitogen-Activated Protein Kinases; Pneumonectomy; Proliferating Cell Nuclear Antigen; Proteins; Pulmonary Artery; Pyrroles; Rats; Rats, Wistar | 2010 |
Effects of atorvastatin and losartan on monocrotaline-induced pulmonary artery remodeling in rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Arterioles; Atorvastatin; Base Sequence; Calcium Channels, L-Type; Disease Models, Animal; DNA Primers; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Pulmonary; Inositol 1,4,5-Trisphosphate Receptors; Losartan; Male; Monocrotaline; Pulmonary Artery; Pyrroles; Rats; Rats, Sprague-Dawley; RNA, Messenger; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum Calcium-Transporting ATPases | 2010 |
[Atorvastatin attenuates hypoxic pulmonary hypertension in rats by inhibiting RhoA/Rho kinase pathway].
Topics: Animals; Anticholesteremic Agents; Atorvastatin; Hemodynamics; Heptanoic Acids; Hypertension, Pulmonary; Hypoxia; Male; Pulmonary Artery; Pyrroles; Random Allocation; Rats; Rats, Wistar; rho-Associated Kinases; rhoA GTP-Binding Protein; Signal Transduction; Ventricular Remodeling | 2011 |
Statin therapy is associated with decreased pulmonary vascular pressures in severe COPD.
Topics: Aged; Atorvastatin; Cross-Sectional Studies; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Pulmonary; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Pulmonary Wedge Pressure; Pyrroles; Regression Analysis; Simvastatin | 2011 |
Peptide-directed highly selective targeting of pulmonary arterial hypertension.
Topics: Amino Acid Sequence; Animals; Drug Delivery Systems; Humans; Hypertension, Pulmonary; Hypoxia; Indoles; Lung; Male; Molecular Sequence Data; Monocrotaline; Peptides; Pulmonary Artery; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, Vascular Endothelial Growth Factor; Time Factors | 2011 |
C-type natriuretic peptide does not attenuate the development of pulmonary hypertension caused by hypoxia and VEGF receptor blockade.
Topics: Animals; Hemodynamics; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Indoles; Lung; Male; Natriuretic Agents; Natriuretic Peptide, C-Type; Protein Kinase Inhibitors; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, Vascular Endothelial Growth Factor | 2011 |
A novel murine model of severe pulmonary arterial hypertension.
Topics: Acute Disease; Animals; Blotting, Western; Cytokines; Disease Models, Animal; Echocardiography; Female; Fluorescent Antibody Technique; Gene Expression Profiling; Hemodynamics; Hypertension, Pulmonary; Hypoxia; Indoles; Lung; Male; Mice; Mice, Inbred C57BL; Pyrroles; Receptors, Vascular Endothelial Growth Factor | 2011 |
Copper dependence of angioproliferation in pulmonary arterial hypertension in rats and humans.
Topics: Animals; Caspases; Cell Division; Cells, Cultured; Chelating Agents; Copper; Diet; Endothelium, Vascular; Enzyme Activation; Humans; Hypertension, Pulmonary; Hypoxia; Immunohistochemistry; Indoles; Male; Microvessels; Molybdenum; Neovascularization, Pathologic; Pyrroles; Rats; Rats, Sprague-Dawley | 2012 |
Severe pulmonary arterial hypertension induced by SU5416 and ovalbumin immunization.
Topics: Animals; Antilymphocyte Serum; Apoptosis; Asparagine; B-Lymphocytes; Caspase Inhibitors; Cell Proliferation; Dexamethasone; Disease Models, Animal; Hemodynamics; Hypertension, Pulmonary; Hypoxia-Inducible Factor 1, alpha Subunit; Immunization; Indoles; Interleukin-6; Lung; Male; Ovalbumin; Proliferating Cell Nuclear Antigen; Pulmonary Artery; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, Vascular Endothelial Growth Factor; Vascular Endothelial Growth Factor A | 2012 |
Effects of multikinase inhibitors on pressure overload-induced right ventricular remodeling.
Topics: Animals; Dose-Response Relationship, Drug; Familial Primary Pulmonary Hypertension; Hypertension, Pulmonary; Indoles; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyrroles; Random Allocation; Rats; Rats, Sprague-Dawley; Sorafenib; Sunitinib; Ventricular Function, Right; Ventricular Remodeling | 2013 |
Atorvastatin prevents dehydromonocrotaline-induced pulmonary hypertension in beagles.
Topics: Alkylating Agents; Animals; Atorvastatin; Cell Proliferation; Cytokines; Dogs; Endothelium, Vascular; Female; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Pulmonary; Lung; Male; Monocrotaline; Muscle, Smooth, Vascular; Nitric Oxide Synthase Type III; Pyrroles | 2012 |
The soluble guanylate cyclase stimulator riociguat ameliorates pulmonary hypertension induced by hypoxia and SU5416 in rats.
Topics: Animals; Apoptosis; Blood Pressure; Blotting, Western; Caspase 3; Cell Proliferation; Cyclic GMP; Guanylate Cyclase; Hemodynamics; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Immunohistochemistry; Indoles; Lung; Male; Nitric Oxide Synthase Type III; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Pyrazoles; Pyrimidines; Pyrroles; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Sildenafil Citrate; Soluble Guanylyl Cyclase; Sulfones; Time Factors; Treatment Outcome | 2012 |
Implication of the ryanodine receptor in TRPV4-induced calcium response in pulmonary arterial smooth muscle cells from normoxic and chronically hypoxic rats.
Topics: Animals; Caffeine; Calcium Channel Agonists; Calcium Signaling; Cell Hypoxia; Cells, Cultured; Dantrolene; Hypertension, Pulmonary; Hypoxia; In Vitro Techniques; Macrocyclic Compounds; Male; Morpholines; Muscle Contraction; Muscle Relaxants, Central; Myocytes, Smooth Muscle; Oxazoles; Patch-Clamp Techniques; Phorbols; Pulmonary Artery; Pyrroles; Rats; Rats, Wistar; Ryanodine; Ryanodine Receptor Calcium Release Channel; TRPV Cation Channels | 2012 |
BDNF/TrkB signaling augments smooth muscle cell proliferation in pulmonary hypertension.
Topics: Animals; Brain-Derived Neurotrophic Factor; Cell Hypoxia; Cell Proliferation; Disease Models, Animal; DNA; Early Growth Response Protein 1; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation; Humans; Hypertension, Pulmonary; Indoles; Ligands; Lung; Male; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Monocrotaline; Myocytes, Smooth Muscle; Protein Binding; Pyrroles; Rats; Receptor, trkB; Signal Transduction | 2012 |
Imatinib attenuates hypoxia-induced pulmonary arterial hypertension pathology via reduction in 5-hydroxytryptamine through inhibition of tryptophan hydroxylase 1 expression.
Topics: Animals; Benzamides; Disease Models, Animal; Hemodynamics; Hypertension, Pulmonary; Hypoxia; Imatinib Mesylate; Indoles; Mice; Mice, Knockout; Phosphorylation; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Pyrroles; Receptor, Platelet-Derived Growth Factor beta; Serotonin; Tryptophan Hydroxylase | 2013 |
Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure.
Topics: Angiography; Animals; Animals, Newborn; Birth Weight; Chronic Disease; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Indoles; Lung; Pulmonary Alveoli; Pulmonary Artery; Pulmonary Circulation; Pyrroles; Rats; Rats, Sprague-Dawley; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Vascular Endothelial Growth Factor; Stress, Physiological | 2002 |
A neutrophil elastase inhibitor reduces cigarette smoke-induced remodelling of lung vessels.
Topics: Analysis of Variance; Animals; Cell Division; Disease Models, Animal; Guinea Pigs; Hypertension, Pulmonary; Leukocyte Elastase; Lung; Muscle, Smooth, Vascular; Pyrroles; Statistics, Nonparametric; Sulfonamides; Tobacco Smoke Pollution | 2003 |
Inhaled nitric oxide attenuates pulmonary hypertension and improves lung growth in infant rats after neonatal treatment with a VEGF receptor inhibitor.
Topics: Administration, Inhalation; Animals; Animals, Newborn; Bronchopulmonary Dysplasia; Enzyme Inhibitors; Female; Humans; Hypertension, Pulmonary; Indoles; Infant, Newborn; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Pregnancy; Pulmonary Alveoli; Pyrroles; Rats; Receptors, Vascular Endothelial Growth Factor | 2004 |
[Effect of elastase inhibitor on pulmonary hypertension induced by monocrotaline].
Topics: Animals; Hypertension, Pulmonary; Male; Monocrotaline; Pancreatic Elastase; Pulmonary Artery; Pyrroles; Rats; Rats, Sprague-Dawley; Sulfonamides | 2004 |
Initial apoptosis is followed by increased proliferation of apoptosis-resistant endothelial cells.
Topics: Apoptosis; bcl-X Protein; Caspase 3; Caspase Inhibitors; Caspases; Caveolin 1; Cell Line; Cell Proliferation; Cycloheximide; Endothelial Cells; Humans; Hypertension, Pulmonary; Indoles; Pyrroles; Receptors, Vascular Endothelial Growth Factor; Shear Strength; Tumor Necrosis Factor-alpha | 2005 |
The protective effect of HMG-CoA reductase inhibitors against monocrotaline-induced pulmonary hypertension in the rat might not be a class effect: comparison of pravastatin and atorvastatin.
Topics: Acetylcholine; Animals; Apoptosis; Atorvastatin; Caspase 3; Endothelial Cells; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Pulmonary; Lung; Male; Monocrotaline; Nitric Oxide Synthase Type III; Nitroprusside; Pravastatin; Pulmonary Artery; Pyrroles; Rats; Rats, Wistar; Ventricular Pressure | 2006 |
Protective effects of atorvastatin in rat models of acute pulmonary embolism: involvement of matrix metalloproteinase-9.
Topics: Acute Disease; Analysis of Variance; Animals; Atorvastatin; Disease Models, Animal; Drug Evaluation, Preclinical; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Pulmonary; Injections, Intravenous; Luminescence; Lung; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Microspheres; Nitrates; Nitrites; Proportional Hazards Models; Pulmonary Embolism; Pulmonary Wedge Pressure; Pyrroles; Random Allocation; Rats; Rats, Wistar; Survival Rate | 2007 |
Rho kinase-mediated vasoconstriction is important in severe occlusive pulmonary arterial hypertension in rats.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Disease Models, Animal; Disease Progression; Endothelin A Receptor Antagonists; Hypertension, Pulmonary; Hypoxia; Indoles; Intracellular Signaling Peptides and Proteins; Male; Myosin-Light-Chain Phosphatase; Organ Culture Techniques; Peptides, Cyclic; Phosphorylation; Protein Serine-Threonine Kinases; Pulmonary Artery; Pyrroles; Rats; Rats, Sprague-Dawley; rho-Associated Kinases; Vascular Endothelial Growth Factor Receptor-2; Vasoconstriction; Vasodilator Agents | 2007 |
Absence of T cells confers increased pulmonary arterial hypertension and vascular remodeling.
Topics: Adoptive Transfer; Angiogenesis Inhibitors; Animals; Dendritic Cells; Disease Models, Animal; Endothelial Cells; Homeostasis; Hypertension, Pulmonary; Immunohistochemistry; Indoles; Injections, Subcutaneous; Male; Pyrroles; Rats; Rats, Nude; Receptors, Vascular Endothelial Growth Factor; T-Lymphocytes | 2007 |
Serotonin transporter protein in pulmonary hypertensive rats treated with atorvastatin.
Topics: Actins; Animals; Anticholesteremic Agents; Atorvastatin; Blood Pressure; Blotting, Western; Dose-Response Relationship, Drug; Echocardiography; Gene Expression Regulation; Heart Ventricles; Heptanoic Acids; Hypertension, Pulmonary; Immunohistochemistry; Male; Muscle, Smooth; Organ Size; Polymerase Chain Reaction; Pulmonary Artery; Pyrroles; Rats; Rats, Sprague-Dawley; RNA, Messenger; Serotonin Plasma Membrane Transport Proteins; Systole | 2007 |
Statin therapy, alone or with rapamycin, does not reverse monocrotaline pulmonary arterial hypertension: the rapamcyin-atorvastatin-simvastatin study.
Topics: Animals; Atorvastatin; Blood Pressure; Disease Progression; Dose-Response Relationship, Drug; Drug Synergism; Echocardiography; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Pulmonary; Male; Monocrotaline; Phosphorylation; Pulmonary Artery; Pyrroles; Rats; Rats, Sprague-Dawley; Ribosomal Protein S6 Kinases, 70-kDa; Simvastatin; Sirolimus | 2007 |
Development of Crotalaria pulmonary hypertension: hemodynamic and structural study.
Topics: Animals; Blood Gas Analysis; Body Temperature; Cardiomegaly; Hemodynamics; Hypertension, Pulmonary; Male; Monocrotaline; Pulmonary Circulation; Pyrroles; Pyrrolizidine Alkaloids; Rats | 1980 |
[Experimental pulmonary hypertension (author's transl)].
Topics: Animals; Cattle; Dogs; Hypertension, Pulmonary; Hypoxia; Monocrotaline; Pyrroles; Pyrrolizidine Alkaloids; Rabbits; Rats; Sheep; Species Specificity; Swine | 1981 |
Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor.
Topics: Animals; Disease Models, Animal; Hypertension, Pulmonary; Male; Monocrotaline; Pancreatic Elastase; Protease Inhibitors; Pyrroles; Rats; Rats, Sprague-Dawley; Sulfonamides | 2000 |
Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Blood Pressure; Caspase 3; Caspases; Cell Death; Cell Division; Endothelium, Vascular; Heart Ventricles; Hypertension, Pulmonary; Hypoxia; Indoles; Male; Muscle, Smooth, Vascular; Myocardium; Pulmonary Artery; Pyrroles; Rats; Rats, Sprague-Dawley; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Vascular Endothelial Growth Factor | 2001 |
Fibrin thrombosis in monocrotaline pyrrole-induced cor pulmonale in rats.
Topics: Animals; Cardiomegaly; Endothelium; Fibrin; Hypertension, Pulmonary; Lung; Male; Monocrotaline; Pulmonary Embolism; Pulmonary Heart Disease; Pyrroles; Pyrrolizidine Alkaloids; Rats | 1977 |
K+ATP-channel activation causes marked vasodilation in the hypertensive neonatal pig lung.
Topics: Adenosine Triphosphate; Animals; Animals, Newborn; Benzopyrans; Cromakalim; Female; Glyburide; Hypertension, Pulmonary; Male; Potassium Channels; Pulmonary Circulation; Pyrroles; Swine; Vasodilation; Vasodilator Agents; Vasomotor System | 1992 |